In CV Disease, Clopidogrel Reduces Nonfatal MI and MACE vs. Aspirin but Not Stroke or Mortality

Authors

Akshay Goel, Westchester Medical Center, New York Medical College, Valhalla, New York, USA (A.G., A.H.M.).
Aaqib H. Malik, Westchester Medical Center, New York Medical College, Valhalla, New York, USA (A.G., A.H.M.).

Author Type(s)

Faculty, Resident/Fellow

Journal Title

Annals of Internal Medicine

First Page

JC137

Document Type

Article

Publication Date

12-1-2022

Department

Medicine

Abstract

Tasoudis PT, Kyriakoulis IG, Sagris D, et al. Thromb Haemost. 2022;122:1879-87. 35577054.

Recommended Citation

Goel, A., & Malik, A. H. (2022). In CV Disease, Clopidogrel Reduces Nonfatal MI and MACE vs. Aspirin but Not Stroke or Mortality. Annals of Internal Medicine, 175 (12), JC137. https://doi.org/10.7326/J22-0094